Wearable bioelectronics enabled by conductive hydrogels: From materials innovation to clinical translation Authors: Zhen-Ping Du, Jun Wang, Ju-Wen Zhang, Ming-Hua Li, Chao-Qun Yan Published: 2026 ABSTRACT AbstractThe rapid evolution of wearable bioelectronics is transforming healthcare toward continuous, non-invasive monitoring and personalized intervention. Central to this progress is the development of materials that integrate mechanical compliance, reliable signal transduction, and long-term biocompatibility. Conductive hydrogels have emerged as a promising platform, combining tissue-like mechanics with tunable ionic/electronic conductivity to enable stable and conformal biointerfaces. This Review examines how materials design and nanocomposite engineering govern charge transport, mechanical robustness, and dynamic responsiveness, and how these structure-property relationships translate into device performance. Representative applications span metabolic, cardiovascular, and neurological monitoring, as well as wound care, sleep analysis, and biomarker detection. We further identify key challenges for clinical translation, including long-term stability, multimodal integration, and data reliability, and outline future directions toward integrated, intelligent, and closed-loop bioelectronic systems.Keywords: Flexible electronics, Conductive hydrogels, Wearable sensors, Non-invasive health monitoring, Chronic disease management Introduction The rising prevalence of chronic diseases has revealed the limitations of traditional intermittent medical monitoring, which fails to support long-term, dynamic disease management [1]. Effective chronic disease care requires continuous tracking of physiological parameters to guide timely interventions. Wearable non-invasive health monitoring devices have therefore emerged as important tools, leveraging advances in electronics, materials science, and data analytics to track parameters such as heart rate, activity, electrophysiology, and glucose-related trends [[2], [3], [4]]. Continuous glucose monitoring systems, for example, have improved glycemic management in diabetes [5]. Despite these advances, conventional wearable sensors still face persistent challenges in durability, comfort, signal stability, and real-world usability [6]. Traditional sensors are prone to motion artifacts and environmental interference, which contribute to measurement inaccuracies [7]. Rigid materials reduce conformability and may cause skin irritation, while conventional data processing algorithms struggle with high-dimensional signals [[8], [9], [10]]. Moreover, poor compatibility with flexible substrates hinders the balance between mechanical stability and sensor performance [11]. Clinical translation is further challenged by the lack of standardized validation protocols [12,13]. Conductive hydrogels address several of these interface-level challenges by combining hydrated polymer networks with ionic or electronic conduction pathways. Their softness and water-rich structure can improve conformal contact, reduce interfacial impedance, and accommodate skin deformation, while conductive fillers or conducting polymers provide signal-transduction pathways [14]. However, these advantages remain material-level attributes unless they are retained after device integration under realistic hydration, strain, and wear conditions. Therefore, high conductivity, stretchability, adhesion, or self-healing should not be interpreted as direct evidence of biomarker accuracy, long-term reliability, manufacturability, or clinical utility. This Review examines hydrogel-enabled bioelectronics from a clinically oriented perspective. Existing reviews have primarily focused on conductive hydrogel chemistry, wearable sensors, soft bioelectronics, and hydrogel biointerfaces [[14], [15], [16]], whereas this Review assesses how hydrogels address defined clinical problems, the evidence supporting their roles, and the barriers to translation. Hydrogel systems across metabolic, cardiovascular, neurological, endocrine, sleep, wound care, and inflammatory monitoring are evaluated within a common clinical framework rather than as isolated demonstrations of material performance. For each platform, we distinguish material performance, device validation, and clinical evidence, and critically examine claims that extend beyond the available data. We also define the specific function of the hydrogel, such as an electrode, adhesive interface, ionic or dielectric layer, sweat collector, membrane, dressing, transducer, or drug reservoir, to clarify its mechanistic contribution. By considering calibration, individual variability, sterilization, manufacturing reproducibility, data security, and reimbursement as design constraints, this Review connects hydrogel innovation with the evidentiary requirements for clinical translation. Materials and device design The design of conductive-hydrogel wearable bioelectronics should begin with the device function that the hydrogel is expected to perform. A formulation optimized as a low-impedance electrophysiological electrode is not necessarily suitable as a sweat-collection membrane, a strain transducer, an antifouling interface, a wound dressing, or a drug-release matrix. Accordingly, this section examines how polymer-network design, conductive-filler architecture, hydration state, and interfacial electrochemistry govern the device-level performance of conductive hydrogels after integration into wearable bioelectronics. Rather than treating conductivity, stretchability, adhesion, and stability as isolated material figures of merit, we focus on how these properties are preserved, coupled, or compromised in working devices. Table 1 provides a side-by-side comparison of seven representative conductive-hydrogel classes, including poly (3,4-ethylenedioxythiophene) (PEDOT), MXene, carbon-nanotube, metal-nanoparticle/nanowire, ionic, organohydrogel, and supramolecular systems, across key material properties, fabrication methods, sensing modes, and limitations. The tabulated values are representative best-in-class results obtained under optimized laboratory conditions and generally do not coexist within a single formulation; the classes should therefore be read as material platforms rather than ranked complete devices, and material-level figures of merit should not be equated with device-level or clinical-level performance. Table 1Comparison of representative hydrogels for wearable bioelectronics.Table 1MaterialsConductivityStretchabilityAdhesionDehydration resistanceFabrication methodSensing modeLimitationsPEDOT:PSS hydrogels [17,18]22.71 S m−1Up to 159%.n.r.Formulation-dependent; one formulation lost 60.1% conductivity on water loss; antifreeze fiber variants improve low-temperature retentionMicrofluidics, ionic crosslinking, polymerization, doping, printing or spinningElectrode + mixed ionic/electronic conductorConductivity realization compromises softness and stretchability. Dehydration shifts device performance.MXene hydrogels [[19], [20], [21]]0.80 S m−11000∼1579%∼10.17 kPa (skin),∼27.12 kPa (glass),∼38.75 kPa (metal)Moisture retention ≈ 8 d; operation to −30 °COne-pot or dual-network preparationElectrode + temperature/strain transducerMXene oxidation and nanosheet restacking alter conductivity.CNT/MWCNT hydrogels [22,23]0.067 S m−1Up to 1821%n.r.24 h water retention at RT>84%Free-radical polymerization with dispersion-assisted CNT incorporationElectrode + piezoresistive strain transducerLong-term reproducibility remains unvalidated.Metal nanoparticle hydrogels [[24], [25], [26]]n.r.n.r.n.r.n.r.Printing, nanostructure transfer or AuNW assemblyElectrode modifier + SERS/electrochemical transducer and sweat interfaceAnalytical sensitivity is device-specific.Ionic hydrogels [27,28]0.877 S m−1 at −20 °CUp to 1825%n.r.Water loss <5% after 100 d in airPhotocrosslinked methacrylated silk-fibroin/PVA PAA/LiClIonic + strain transducerReal-sweat calibration drift, LiCl exposure and batch manufacturing need evaluation.Organohydrogels [29,30]1.25 S m−1 at RT;1.01 S m−1 at −20 °CUp to 681%n.r.Freezing/drying resistance ≥7 dSolvent displacement or one-pot UV preparation.Self-adhesive ionic conductor + strain/temperature transducerTranslational readiness depends on solvent, skin tolerance, packaging, and shelf-life stability.Supramolecular hydrogels [31,32]0.15∼0.44 S m−1 (β-CD system)Up to ∼3000%Up to 27 kPa.n.r.One-pot graft/copolymerization or two-step PPy network formationAdhesive interface + strain transducer via dynamic host-guest/supramolecular networksDynamic bonds benefit self-healing but cause time-dependent baseline drift after long-term operation.Abbreviations: AuNW, gold nanowire; β-CD, beta-cyclodextrin; CNT, carbon nanotube; LiCl, lithium chloride; MWCNT, multi-walled carbon nanotube; MXene, two-dimensional transition-metal carbide/nitride/carbonitride; PAA, poly(acrylic acid); PEDOT:PSS, poly(3,4-ethylenedioxythiophene):poly(styrene sulfonate); PPy, polypyrrole; PVA, poly(vinyl alcohol); RT, room temperature; SERS, surface-enhanced Raman scattering; UV, ultraviolet; n.r., not reported. Comparison of representative hydrogels for wearable bioelectronics. Abbreviations: AuNW, gold nanowire; β-CD, beta-cyclodextrin; CNT, carbon nanotube; LiCl, lithium chloride; MWCNT, multi-walled carbon nanotube; MXene, two-dimensional transition-metal carbide/nitride/carbonitride; PAA, poly(acrylic acid); PEDOT:PSS, poly(3,4-ethylenedioxythiophene):poly(styrene sulfonate); PPy, polypyrrole; PVA, poly(vinyl alcohol); RT, room temperature; SERS, surface-enhanced Raman scattering; UV, ultraviolet; n.r., not reported. Hydrogel fundamentals and key properties Hydrogels are polymer materials with a three-dimensional network structure. Due to their high hydrophilicity, adjustable mechanical properties, and good biocompatibility, they have wide potential applications in the biomedical field [33]. Hydrogels can absorb large amounts of water, creating a moist environment similar to biological tissues, which promotes wound healing and cell growth. The mechanical properties of hydrogels, including elastic modulus and hardness, can be precisely regulated through polymer composition, crosslinking density, or incorporation of nanocomposites, enabling adaptation to diverse biomedical applications [34]. For wearable bioelectronics, hydrogels should be evaluated less as generic water-rich biomaterials and more as functional biointerfaces. The decisive properties are modulus matching, swelling ratio, water-retention capacity, adhesion and removal trauma, ionic mobility, electrochemical stability window, interfacial impedance, and mechanical fatigue resistance under repeated skin deformation. These parameters determine whether a hydrogel can maintain electrical coupling and analytical stability during realistic wear. Among biocompatible matrices used in skin-worn devices, carboxymethyl cellulose (CMC) hydrogels illustrate how tunable mechanics, thermal responsiveness, and self-healing can be exploited for soft sensing interfaces (Fig. 1a) [18,35,38]. Design and fabrication strategies for multifunctional hydrogels and hydrogel nanocomposites. (a) One-pot synthesis and mechanism of a carboxymethyl cellulose-based smart conductive hydrogel. Reproduced with permission from Ref. [35]. Copyright 2024 Elsevier. (b) Schematic illustration of hydrogel fiber preparation via ionic crosslinking and covalent crosslinking. Reproduced with permission from Ref. [18]. Copyright 2024 MDPI. (c) Network engineering of PEDOT-based conductive hydrogels (P-CHs). Reproduced with permission from Ref. [17]. Copyright 2025 Wiley. (d) Five routes to homogeneously dispersed hydrogel-nanoparticle conjugates. Reproduced with permission from Ref. [36]. Copyright 2015 Wiley. (e) Synthetic schemes and photographs of MXene hydrogels and MXene organohydrogels. Reproduced with permission from Ref. [37]. Copyright 2024 Springer Nature. (f) Polyacrylamide-oxidized multiwalled carbon nanotube hydrogel via ammonium persulfate (APS)-initiated free-radical polymerization. Reproduced with permission from Ref. [22]. Copyright 2020 Elsevier. Conductive hydrogels, particularly PEDOT-based conductive hydrogels (P-CHs), broaden the applicability of hydrogels to flexible electronics and biosensing owing to their high electrical conductivity. For wearable devices, these materials are often processed into hydrogel fibers, which can be fabricated through ionic crosslinking and covalent crosslinking (Fig. 1b) [18]. Beyond macroscopic form factors, their performance is governed by the underlying network architecture, which can be tailored through physical crosslinking, chemical crosslinking, or combined physico-chemical crosslinking (Fig. 1c) [17]. Physical crosslinking generates dynamic networks that enhance flexibility and self-healing, whereas chemical crosslinking improves mechanical robustness. Importantly, integrating nanofillers with dual crosslinking schemes can simultaneously boost conductivity and mechanical strength. For example, polyPEDOT:PSS nanocomposite hydrogels assembled from polymer nanosheets have been reported to increase conductivity ∼3.8-fold and roughly double mechanical strength relative to the unmodified matrix; whether these co-occurring gains translate into the sensitivity and baseline stability required of a working electrochemical sensor remains to be demonstrated at the device level [18]. Charge-transport mechanisms and structure–property relationships Conductive hydrogels carry charge through two physically distinct mechanisms. Ionic conductors rely on mobile hydrated ions (Na+, K+, Cl−) migrating through the water-swollen network, conferring tissue-like softness but modest, frequency-dependent conductivity. Electronic conductors carry charge along conjugated-polymer backbones (PEDOT, PANI) or through percolating filler networks (CNTs, MXene, metal nanowires), enabling higher direct-current conductivity at the cost of increased stiffness. Most skin-interfacing hydrogels operate as mixed conductors, and their relative contributions should be resolved by electrochemical impedance spectroscopy (EIS) with equivalent-circuit fitting, since the dominant pathway determines whether resistive, capacitive, impedimetric, or faradaic transduction is appropriate [15,17,39,40]. Electronic conduction in filler-reinforced systems follows percolation scaling σ ∝ (φ – φc)t above a critical volume fraction φc. High-aspect-ratio one-dimensional (CNTs, AgNWs) and two-dimensional (MXene, graphene) fillers achieve percolation at far lower loadings than quasi-spherical particles, preserving low modulus and stretchability; loading beyond the optimum promotes aggregation and stiffening without proportional conductivity gain [36,39,41]. For conducting-polymer systems, secondary doping or template assembly establishes an analogous bicontinuous percolating network through the hydrated matrix [18,22,42]. Hydrogel conductivity varies with hydration state rather than being a fixed material constant. Swelling increases inter-particle separation and suppresses percolating contacts, while dehydration depletes ion mobility and widens tunneling gaps. Continuous modulation of skin-surface hydration by sweat, humidity, and temperature therefore couples directly to the sensor baseline and is a primary source of drift and moisture cross-sensitivity [[43], [44], [45]]. Performance at sensing interfaces is governed by interfacial impedance rather than bulk conductivity. EIS resolves charge-transfer resistance (Rct) and double-layer capacitance, which together control skin–electrode coupling in electrophysiology and faradaic transduction in electrochemical sensing, where redox mediators such as Prussian blue or aptamer conformational changes modulate Rct to generate the analytical signal [14,26,40,[46], [47], [48], [49], [50]]. Under mechanical deformation, stretching widens tunneling gaps and nucleates microcracks through percolating networks, increasing resistance and producing hysteresis, drift, and cycle-to-cycle degradation that limit device reproducibility [45,51]. Three practical design rules follow: report conductivity together with hydration state; quantify interfacial impedance rather than bulk conductivity alone; and evaluate strain response by linearity, hysteresis, and drift rather than gauge factor alone. Nanocomposite fabrication and performance enhancement The performance of conductive hydrogel sensors critically depends on the architecture of the nanocomposite network. Two primary loading strategies, i.e., covalent crosslinking and physical incorporation, enable the integration of functional nanomaterials into the hydrogel matrix, and the rational selection of these approaches is essential for simultaneously achieving high conductivity, mechanical robustness, and flexibility. To date, several representative nanocomposite construction strategies have been widely adopted (Fig. 1d) [36]. These strategies enhance hydrogel performance through distinct mechanisms: (I) gelation occurring in a nanoparticle suspension, enabling homogeneous incorporation; (II) physical embedding of nanoparticles into a preformed hydrogel matrix; (III) reactive formation of nanoparticles within an existing gel network; (IV) nanoparticle-mediated crosslinking to construct mechanically reinforced networks; and (V) synergistic gel formation using nanoparticles, polymers, and distinct gelator molecules to optimize multifunctional properties. Among advanced fillers, MXene, a family of two-dimensional transition metal carbides, nitrides, and carbonitrides, have emerged as high-performance additives due to their excellent conductivity and abundant surface functional groups [41]. MXene-based hydrogels, crosslinked physically or chemically, achieve uniform dispersion, stable encapsulation, and enhanced electron mobility, resolving the trade-off between conductivity and mechanical flexibility (Fig. 1e) [37]. Carbon nanotubes (CNTs) also significantly improve hydrogel electrochemical performance. Oxidized multi-walled CNTs (oxCNTs) integrated into polyacrylamide (PAAm) hydrogels form uniform conductive networks through physical or chemical crosslinking. Oxygen-containing functional groups improve dispersion and interfacial interactions, thereby enhancing both mechanical stability and sensor sensitivity (Fig. 1f) [22]. Optimizing oxCNT concentration and surface chemistry further strengthens network uniformity and electrochemical performance, enabling high-sensitivity, low-power wearable devices; however, the impact of these advances on long-term wearable accuracy remains to be validated under integrated conditions involving hydration, motion, and sweat exposure [42]. Advanced fabrication techniques, including electrospinning, 3D printing, laser carbonization, and solvothermal synthesis, enable precise control over nanocomposite architecture, further improving conductivity, functional integration, and target enrichment [[52], [53], [54]]. Surface functionalization and interface engineering at the atomic scale, guided by modeling and nonequilibrium Green's function simulations, can enhance signal conversion efficiency, sensitivity, and biocompatibility, optimizing the overall sensor performance [46,47]. Dynamic response function and anti-interference strategies The dynamic responsiveness of nanohydrogels represents a central advantage for wearable sensing applications, enabling sensitive and reversible responses to external stimuli such as temperature, pH, mechanical strain, and electric fields. This behavior arises from the reversible reconfiguration of dynamic interactions within the polymer network, including hydrogen bonding, ionic coordination, and hydrophobic interactions, combined with efficient electrical signal transduction enabled by conductive nanofillers, such as MXene and carbon nanotubes. Temperature-responsive hydrogels, for instance, undergo volume phase transitions that allow rapid thermal sensing and regulation, while electric-field or strain-induced network rearrangements enable controlled drug release and high-precision mechanical sensing [19,[55], [56], [57]]. MXene-based nanocomposite hydrogels have demonstrated gauge factors up to 3.61 over strain ranges of 0–200%, allowing the detection of subtle human motions [19,20]. Multi-stimulus responsiveness further expands hydrogel functionality, enabling simultaneous responses to temperature, pH, light, or mechanical cues. In wearable bioelectronics, however, multi-responsiveness is useful only when the target signal can be separated from environmental cross-sensitivity. Intrinsic self-healing and antifreeze properties can extend operation under low-temperature or mechanically demanding conditions, but they do not by themselves guarantee analytical stability during on-skin use [43,[58], [59], [60], [61]]. Accordingly, dynamic response should be evaluated together with baseline drift, hysteresis, cross-sensitivity, and recovery after repeated deformation. Reliable operation under real-world conditions requires effective mitigation of motion artifacts and environmental interference. Mechanical adaptability and interfacial stability are therefore critical design considerations. Dual-network architectures and ionic liquid incorporation enhance flexibility, adhesion, and mechanical damping, reducing signal distortion caused by motion [62,63]. Microstructural engineering, such as the introduction of porous ionic channels, further improves signal fidelity and response stability [43,64]. Multimodal sensing combined with intelligent signal processing enables the decoupling of physiological signals from motion-induced noise. Multidimensional signal analysis and machine learning algorithms have been increasingly adopted to enhance accuracy and robustness under dynamic conditions [62,63,65]. Environmental compensation strategies are equally important for maintaining sensor performance across varying temperature and humidity conditions. Antifreeze additives, dual-network designs, and dual-catalytic systems enable stable operation over broad temperature ranges (−80 to 80 °C), mitigating performance degradation due to freezing or dehydration [43,[66], [67], [68]]. For example, lignin-polyacrylamide composite hydrogels retain high conductivity at low temperatures, while hydrophobic–hydrophilic phase-separated co-gels improve water resistance [44,69]. Further integration of functional materials with intelligent algorithms has enabled real-time environmental compensation, as demonstrated by modified lignin–tannin hydrogels coupled with convolutional neural networks to maintain sensing reliability across diverse environments [70]. Flexible and stimuli-responsive sensor platforms For clinical translation, the adaptability of hydrogel-based sensors must be optimized across multiple dimensions, including biocompatibility, functional integration, signal stability, and operational safety. At the materials level, supramolecular engineering and biocompatibility-oriented design play central roles in minimizing toxicity while maintaining mechanical and electrical performance. For instance, pseudo-sliding-ring hydrogels constructed from polyacrylamide (PAAm), β-cyclodextrin, and bio-ionic liquids achieve ultrahigh stretchability (up to 3000%), autonomous self-healing, and biodegradability without chemical crosslinkers, substantially reducing potential biological risks [32]. Similarly, MXene-biopolymer hydrogels combine self-adhesiveness with ultraviolet shielding while enabling high-fidelity electrophysiological signal acquisition, supporting long-term wearable diagnostics [71]. Beyond materials design, the integration of advanced sensing technologies with clinically relevant use scenarios has become a defining trend. Wireless and battery-free immunosensors enable rapid virus antigen detection at femtogram-per-liter levels within minutes, supporting large-scale community screening [72]. Electrochemical skin patches based on molecularly imprinted polymers allow in situ quantification of epidermal biomarkers, providing new tools for skin barrier evaluation and personalized healthcare [73]. Photo-crosslinked ionogel sensors further expand application boundaries by offering extreme stretchability (>1825%), ultralow-temperature tolerance (−85 °C), and operational lifetimes exceeding two years, meeting the stringent requirements of long-term implantation [28]. User comfort and system safety are equally critical for sustained wearable use. Breathable adhesive interfaces mitigate skin irritation while maintaining stable contact; for example, sensors combining conductive polymers with silk fibroin hydrogels exhibit adhesion strengths exceeding 20 kPa and breathability three times higher than that of commercial dressings, reducing skin irritation by more than 70%. Reliable power supply solutions further support continuous operation, as demonstrated by flexible zinc-based batteries delivering open-circuit voltages of 1.4 V and power densities up to 72 μW cm−2 [74]. From a functional perspective, multimodal sensing and minimally invasive strategies significantly enhance monitoring accuracy and versatility. Supramolecular conducting polymer hydrogels (SCPHs), formed through the integration of conductive polymers and supramolecular networks, provide a unique combination of electrical conductivity and mechanical compliance. Composite SCPHs employing multiple physical crosslinking mechanisms form uniform, stable networks with high tensile strength, excellent extensibility, and suppressed swelling, enabling reliable sensing in complex physiological environments [31]. Temperature-responsive sensors Temperature-responsive SCPH sensors operate through thermally induced modulation of conductive pathways. Temperature variations dynamically alter polymer chain conformation and supramolecular bonding states, which in turn regulate carrier mobility and ionic transport within the network. These reversible changes adjust the connectivity of conductive domains, producing measurable resistance variations that enable high-sensitivity thermal detection [75]. Fig. 2a shows that thermal stimulation reorganizes the supramolecular network, shifting conductive pathways and yielding clear resistance modulation. The resistance–time profiles resolve practical temperature inputs: alternating cold-hot water produces opposite resistance trends, enabling reliable discrimination between heating and cooling with a stable baseline. The sensor also tracks respiratory airflow, where periodic resistance oscillations correspond to inhalation/exhalation-driven local temperature changes. Overall, the repeatable cyclic signals indicate robust performance for respiratory monitoring and wearable skin-temperature tracking [82]. Hydrogel-based wearable sensors for multimodal environmental and electrophysiological monitoring. (a) Temperature-responsiveness of supramolecular conducting polymer hydrogel (SCPH) sensor. Reproduced with permission from Ref. [75]. Copyright 2024 Wiley. (b) Transparent, ultrastretchable soft skin-like triboelectric nanogenerator for tactile sensing. Reproduced with permission from Refs. [76,77]. Copyright 2017, American Association for the Advancement of Science; and Copyright 2024 Wiley. (c) Wireless self-powered NO2 gas sensor. Reproduced with permission from Ref. [78]. Copyright 2024 Springer Nature. (d) In situ forming dual-conductive PEDOT:PSS/SBMA/PEGDA (PSP) hydrogel epidermal electrodes for high-fidelity surface electromyography (EMG) recording. Reproduced with permission from Ref. [79]. Copyright 2023, Wiley. (e) SCPH-based hydrogel sensor for electrocardiogram (ECG) monitoring. Reproduced with permission from Ref. [80]. Copyright 2021, Elsevier. (f) Hydrogel-integrated wearable brain-machine interface (BMI) for electrooculography (EOG) monitoring. Reproduced with permission from Ref. [81]. Copyright 2022 Elsevier. Tactile-responsive sensors Tactile-responsive platforms increasingly employ soft triboelectric nanogenerators (STENGs) with sandwich architectures that balance stretchability and mechanical stability. Multi-layer interfaces enhance triboelectric charge generation and collection efficiency, overcoming fatigue and performance degradation commonly observed in single-layer systems. Transparent polymers or ionic liquid electrodes ensure efficient charge transfer while maintaining comfort and wearability [83]. In the representative PAAm–LiCl/elastomer sandwich STENG structure, the polyacrylamide-based ionic conductive hydrogel functions as the deformable ionic-conductor electrode: its high ionic conductivity and electrochemically stable metal/hydrogel interfacial coupling enable efficient triboelectric charge collection even under large mechanical deformation, thereby maintaining output signal stability and underpinning the ultrahigh stretchability (uniaxial strain up to 1160%) and high transparency (average transmittance ∼96.2%) that distinguish this class of tactile platform. Performance is further enhanced by incorporating nanoparticle-doped composite films to increase surface charge density and dielectric polarization. Conductive interlayers, such as MXene nanosheets, modulate dielectric properties and suppress charge leakage, thereby improving output stability [84]. High-temperature STENG-based tactile sensors convert mechanical stimuli into electrical signals through temperature-modulated ionic mobility within the electrode layer. Asymmetric multimodal structures enable independent pressure and temperature signal outputs, maintaining rapid response and high recognition accuracy even at temperatures approaching 200 °C [85]. Accordingly, the combination of transparency, ultrastretchability, and robust signal output demonstrated in Fig. 2b makes these tactile platforms highly suitable for intelligent prosthetics, soft robotics, and tactile monitoring in extreme or thermally fluctuating environments. Gas-responsive sensors Hydrogel-based gas sensors have emerged as promising platforms for selective NO2 detection due to their flexibility, biocompatibility, and tunable chemistry. Sensitivity can be enhanced through supramolecular interactions, molecular crystallization, and electrostatic regulation, enabling rapid and reversible NO2 adsorption–desorption processes while preserving mechanical integrity [86]. In these sensing platforms, the conductive hydrogel matrix, such as polyacrylamide (PAAm)-based ionic gel architectures incorporating zinc salt electrolytes, serves both as the ion-conducting sensing layer and as the skin-adhesive interface. Tunable ionic mobility within the polymer network governs the electrochemical response kinetics of the integrated power source and determines gas detection sensitivity. Meanwhile, the hydrogel's intrinsic mechanical compliance and self-adhesive properties enable conformal attachment to the skin and help maintain stable electrical performance during wearable operation. Salt-impregnation strategies, such as CaCl2 incorporation, significantly reduce detection limits (down to 86 parts per trillion (ppt)) and improve response-recovery kinetics [87]. Self-healing characteristics further ensure long-term stability. To improve portability and field deployment, wireless and self-powered configurations have been developed; for example, integration with zinc–air batteries enables sensitive NO2 detection under ambient conditions and supports signal recording, alarming, and wireless transmission for remote monitoring (Fig. 2c) [88]. Metal-organic framework (MOF)-MXene composite hydrogels further improve selectivity and response speed (down to 0.9 s), highlighting the potential of hybrid architectures for air-quality monitoring and wearable environmental sensing [89]. Electrical signal-responsive sensors Hydrogel-based electrodes enable high-fidelity acquisition of electrophysiological signals such as ECG and EOG by reducing interfacial impedance and improving conformal skin contact. Multi-physically crosslinked SCPHs based on PVA and PAAm exhibit excellent stretchability and conductivity, allowing stable adhesion during motion and minimizing signal artifacts [90]. These electrodes maintain electrical integrity through self-healing mechanisms, supporting long-term wearable use with reduced maintenance. As demonstrated by polyaniline-copolymer hydrogel systems, clear ECG and EOG waveforms can be continuously recorded with high signal-to-noise ratios (Fig. 2d–f) [91]. By combining mechanical compliance, low interfacial impedance, and intrinsic biocompatibility, SCPH electrodes provide a robust material foundation for next-generation wearable diagnostics and human–machine interfaces. Medical applications of conductive hydrogels In 3.1, 3.2, 3.3, 3.4, 3.5, we focus on representative platforms selected according to three criteria. First, the device must employ a conductive hydrogel in a defined functional role. Second, it must target a specific clinical monitoring scenario rather than serve as a generic sensing demonstration. Third, when available, it should report device performance using data acquired on the body or from biofluids, so that evidence at the material, device, and clinical levels can be clearly distinguished. When a widely cited platform is included despite limited validation, it is retained as an illustrative concept and labeled accordingly on the evidence scale. Quantitative performance metrics for the representative platforms discussed below are summarized in Table 2. Table 2Performance comparison of wearable hydrogel-based biosensing and physical-sensing platforms.Table 2PlatformApplicationHydrogel functionDetection limitsLinear rangeSensitivity & response timeHysteresis & driftDurability cyclesOn-body testing durationClinical reference comparisonPassive perspiration glucose patch [92]Sweat glucoseSweat collectionn.r.n.r.Sensor response E(t) increased ∼20–40 min after the onset of BG rise in healthy subjects, with E(t) and BG peaks ∼15–20 min apart, indicating a BS lag.Swelling-related driftn.r.2–5 h post-meal monitoringvs. fingerstick BG meter: 10.56%/13.17% mean deviation at fingertip/forearm; strong fingertip correlation (Pr = 0.94).Pt/MXene glucose sensor [93]Sweat glucoseImmobilizing MXene29.15 μmol/L (S/N = 3)0–1 mmol/L (R2 = 0.9793, flexible sensor); Pt/MXene/GCE: 0–8 mmol/L, R2 = 0.992∼3.43 μA mM−1 cm−2 under continuous read-outn.r.n.r.1 d arm-sweat monitoring (30 min before and 1 h after each meal)n.r.Wearable hydrogel SERS chip [24]UA; lactic acidPumping sweat through plasmonic trimersn.r.n.r.n.r.n.r.No difference in SERS signals after 500 bending cyclesn.r.n.r.FlexoSERS AuNW sensor [25]UA; pH3D-printed hydrogel collector + stretchable Au-nanowire SERS filmUA: 5.16 μmol/LUA: 10–100 μmol/L; pH: 4.2–7.8EF 3.3 × 1010, signal retained even under 50% strainNot obviousRobust over 2500 stretch–release cycles60 min anaerobic-exercise monitoring; 60 d regular-exercise follow-upn.r.Epidermal secretion patch [94]UA; pH; Na+Sebum-filtering interfacen.r.n.r.UA sensor sensitivity: 5.44 μA mM−1 over 12.5–100 μM; pH sensor sensitivity: 58.4/59.6 mV dec−1 with/without membrane; Na+ sensor sensitivity: 46.7/52.4 mV dec−1 with/without membranen.r.n.r.20 min treadmill warm-up; 20 min stationary cycling testvs. LC-MS/pH meter/ICP-MS: 16.67%/7.01%/9.25% mean deviation for UA/pH/Na+.BP hydrogel pressure sensor [27]Pulse; BPCapacitive dielectricn.r.0–290 kPaS1 = 37.94 kPa−1 (0–25 kPa); 40.78 kPa−1 (1.3–100 Pa)Long-term water retention (low drift claimed)Stable >2000 cycles; dielectric exposed to air up to 100 daysn.r.vs. cuff BP (n = 143): 3.37/1.90/2.35 mmHg SD for SBP/DBP/MAP (R2 = 0.967/0.956/0.959); AAMI pass; BHS Grade A.EEG hydrogel interface [95]ECG, EEG, and EMG biosignal recordingConductive skin-electrode interfacen.r.n.r.n.r.n.r.n.r.Five 30 s ECG/EEG; 100 × 5 s EMG per gesturen.r.Silk-based degradable bio-interface [96]Seizure-monitoring conceptDegradable silk biointerfacen.r.n.r.Pressure sensitivity S ≈ 0.3 kPa−1 (<500 Pa); gauge factor ≈ 1.1 (strain); response time ≈ 0.1 sn.r.>7000 loading–unloading cycles at 2 kPa, 5 Hz (>1400 s test duration)n.r.n.r.L-Dopa sweat sensor [97]Levodopa therapeutic drug monitoring (Parkinson's)Sweat collection and transport∼300 nM5–30 μmol/LCurrent sampled every ≈ 10 minn.r.n.r.100 min post-tablet fingertip-sweat PK (10 min intervals)vs. finger-prick capillary blood samples (n = 2): strong temporal correlation (Pr = 0.94/0.87); ∼10 min sweat lag.CRP sweat patch [98]Inflammation CRPSweat extractionCRP: 8 pM0–20 ng/mL (PBS)n.r.Drift mitigated by on-chip pH/temp/ionic-strength calibrationn.r.5 min iontophoresis +12–32 min on-arm CRP readoutvs. serum CRP (n = 80): strong correlation (r = 0.844, P < 0.00001).Abbreviations: AAMI, Association for the Advancement of Medical Instrumentation; AuNW, gold nanowire; BG, blood glucose; BHS, British Hypertension Society; BP, blood pressure; BS, blood-to-sweat; CRP, C-reactive protein; DBP, diastolic blood pressure; ECG, electrocardiogram; EEG, electroencephalography; EF, enhancement factor; EMG, electromyography; E(t), time-dependent sensor electrical potential output; GCE, glassy carbon electrode; ICP-MS, inductively coupled plasma mass spectrometry; L-Dopa, levodopa; LC-MS, liquid chromatography–mass spectrometry; MAP, mean arterial pressure [=(SBP + 2 × DBP)/3]; MXene, Ti3C2Tx, two-dimensional transition-metal carbide material; n.r., not reported; PBS, phosphate-buffered saline; PK, pharmacokinetic; Pr, Pearson's correlation coefficient; SBP, systolic blood pressure; SD, standard deviation; SERS, surface-enhanced Raman spectroscopy; S/N, signal-to-noise ratio; UA, uric acid. Performance comparison of wearable hydrogel-based biosensing and physical-sensing platforms. Abbreviations: AAMI, Association for the Advancement of Medical Instrumentation; AuNW, gold nanowire; BG, blood glucose; BHS, British Hypertension Society; BP, blood pressure; BS, blood-to-sweat; CRP, C-reactive protein; DBP, diastolic blood pressure; ECG, electrocardiogram; EEG, electroencephalography; EF, enhancement factor; EMG, electromyography; E(t), time-dependent sensor electrical potential output; GCE, glassy carbon electrode; ICP-MS, inductively coupled plasma mass spectrometry; L-Dopa, levodopa; LC-MS, liquid chromatography–mass spectrometry; MAP, mean arterial pressure [=(SBP + 2 × DBP)/3]; MXene, Ti3C2Tx, two-dimensional transition-metal carbide material; n.r., not reported; PBS, phosphate-buffered saline; PK, pharmacokinetic; Pr, Pearson's correlation coefficient; SBP, systolic blood pressure; SD, standard deviation; SERS, surface-enhanced Raman spectroscopy; S/N, signal-to-noise ratio; UA, uric acid. Metabolic disease monitoring Continuous glucose monitoring in diabetes Sweat-based glucose sensing should be evaluated as an investigational metabolic-sensing route rather than as a direct equivalent of blood glucose or interstitial fluid (ISF) continuous glucose monitoring (CGM). Reported associations between sweat and blood glucose are context-dependent and affected by sweat rate, dilution, skin contamination, evaporation, local metabolism, sampling lag, and variable partitioning between blood, interstitial fluid, and sweat [[99], [100], [101], [102], [103], [104]]. Current sweat-glucose wearables, therefore, remain largely investigational or fitness-oriented, and the central question for hydrogel-enabled devices is whether the sampling interface and sensing electrode can deliver reference-comparable accuracy under realistic wear conditions. In permeation-enhanced sweat-extraction systems, the hydrogel primarily functions as a sweat-collection membrane and adhesive skin interface (Fig. 3a) [92]. Controlled extraction rates of 75–400 nL min−1 demonstrate device-level feasibility, but clinical interpretation still depends on calibration, sweat availability, sampling lag, and comparison with accepted reference methods; this platform is therefore best classified as an on-body pilot demonstration. Among sensing strategies, glucose oxidase systems provide selective faradaic transduction, but enzyme activity, mediator stability, and hydrogel hydration govern drift and lifetime [[48], [49], [50],107]. Non-enzymatic Pt/MXene electrodes avoid enzyme degradation yet require separate validation for selectivity, antifouling performance, and reference-method comparison. A representative Pt/MXene flexible sensor integrated with a dual-reservoir microfluidic patch (Fig. 3b) supports wearable sweat-glucose sensing during prolonged wear, but blood- or ISF-equivalent accuracy has not been demonstrated in a sufficiently powered independent cohort [93]. Wearable biofluid glucose-sensing platforms for continuous and minimally invasive monitoring. (a) Passive perspiration-inspired wearable system for continuous glucose monitoring. Reproduced with permission from Ref. [92]. Copyright 2024 Wiley. (b) Flexible wearable non-enzymatic electrochemical glucose sensor based on Pt/MXene electrode. Reproduced with permission from Ref. [93]. Copyright 2023 American Chemical Society. (c) Comparison of minimally invasive interstitial fluid (ISF) microneedle-based continuous glucose monitoring and non-invasive microfluidic sweat sensing. Reproduced with permission from Ref. [105]. Copyright 2024 American Chemical Society. (d) Smart contact lens for in vivo tear-glucose monitoring and on-demand ocular drug delivery. Reproduced with permission from Ref. [106]. Copyright 2020 American Association for the Advancement of Science. Clinically established CGM systems predominantly target ISF and therefore provide the appropriate benchmark (Fig. 3c). Commercial platforms from Dexcom and Abbott use minimally invasive subcutaneous sensing elements, whereas sweat-based devices must additionally address sweat availability, sweat-rate dependence, contamination, evaporation, and sampling lag [105]. Pharmacological sweat induction, such as pilocarpine-assisted stimulation, may improve sample availability but introduces additional calibration, usability, and safety requirements. Sweat-glucose platforms therefore remain investigational or fitness-oriented rather than regulatory-cleared diagnostic CGM systems, and reference-comparable accuracy cannot be claimed until these confounders are systematically addressed. Beyond sweat, tears have emerged as another attractive non-invasive biofluid for glucose monitoring. Recently developed smart contact lenses (Fig. 3d) integrate glucose sensing with electro-controlled drug delivery, enabling on-demand therapeutic release through wireless power transfer and remote control. Such multifunctional platforms offer a compelling approach for the treatment of diabetes-associated ocular complications, including diabetic retinopathy [106]. Uric acid, pH, and electrolyte sensing for kidney-related metabolic monitoring Wearable sweat sensors have been explored for kidney-related metabolic monitoring, particularly through uric acid, lactate, pH, and electrolytes such as sodium. These readouts can provide useful physiological trends related to hydration status, exercise metabolism, or altered excretion patterns, but they should not be treated as direct substitutes for clinically established renal-function markers unless quantitative agreement with blood or urine reference measurements is demonstrated. For the hydrogel surface-enhanced Raman scattering (SERS) and FlexoSERS examples, the hydrogel contribution is primarily a sweat-collection layer and/or SERS-active transducer (Fig. 4a and b) [24,25]. Reported sweat–serum trends and strain-stable SERS responses are encouraging, but they remain trend-level demonstrations unless cohort-level agreement statistics and clinical decision thresholds are established. Sebaceous interference illustrates why device architecture can be as important as hydrogel chemistry in sweat analysis. Hydrogel-based filtration membranes and microfluidic channels can serve as sampling and antifouling components, helping separate sweat from sebum and transport fresh sweat to the sensors (Fig. 4c) [94]. Such designs improve analytical reliability, but the reported accuracy should be interpreted in relation to the stated reference method, sweat-flow condition, participant number, and duration of wear. Hydrogel-enabled wearable sweat-analysis platforms. (a) Wearable hydrogel SERS chip for label-free detection of sweat metabolites. Reproduced with permission from Ref. [24]. Copyright 2024 American Chemical Society. (b) Stretchable FlexoSERS sensor based on a jellyfish-like gold nanowire (J-AuNW) plasmonic substrate. Reproduced with permission from Ref. [25]. Copyright 2024 American Chemical Society. (c) Epidermal biosensing patch integrating hydrogel sebum-filtering membrane and unidirectional-flow microfluidic channels for sweat/sebum separation and fresh-sweat transport. Reproduced with permission from Ref. [94]. Copyright 2025 Elsevier. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) Cardiovascular health monitoring Cardiovascular monitoring highlights a different hydrogel function from sweat biochemistry: here, the hydrogel usually serves as a soft electrode, dielectric layer, adhesive interface, or pressure-transducing medium. The translational value of such systems depends on whether conformal contact and low impedance translate into stable pulse-wave, ECG, or bioimpedance signals during daily motion. Thus, cardiovascular examples should be evaluated by signal fidelity, calibration stability, artifact rejection, reference-method comparison, and independent validation rather than by pressure sensitivity or artificial intelligence (AI) classification accuracy alone. Representative cardiovascular monitoring modalities, including pulse pressure sensing, photoplethysmography (PPG), ECG, bioimpedance, seismocardiography (SCG), ballistocardiography (BCG), and ultrasound, capture distinct electrical, mechanical, and hemodynamic signals, as shown in Fig. 5a. AI algorithms can assist feature extraction and pattern recognition from these high-dimensional recordings, but their clinical value requires external validation on independent cohorts, transparent artifact handling, and comparison with accepted clinical references. [108] For this reason, the AI workflow in Fig. 5b should be read as system-level context, whereas the hydrogel-specific contribution lies in the soft sensing interface and pressure-transduction layer. AI-enabled cardiovascular health monitoring. (a) Workflow of cardiovascular monitoring integrating wearable devices with AI for disease screening. Reproduced with permission from Ref. [108]. Copyright 2024 Elsevier. (b) General pipeline of AI-assisted medical diagnosis. Left: model establishment from large-scale datasets. Right: diagnostic inference and clinical decision-making. (c) Wearable pulse-pressure sensor for arterial blood-pressure monitoring. Reproduced with permission from Ref. [27]. Copyright 2024 American Chemical Society. The multi-crosslinked double-network ionic hydrogel pressure sensor illustrates how the hydrogel functions as a pressure-transducing dielectric layer that converts arterial pulsation into a stable capacitive signal (Fig. 5c) [27]. Its high pressure resolution, broad detection range, and benchtop durability support device-level feasibility. However, neural-network-derived blood pressure (BP) values should be described as model-based cuffless BP estimation, not direct BP measurement, unless prospectively validated against accepted cuff-based protocols in representative populations. The immediate translational requirement is therefore independent validation of blood pressure measurements across calibration states, skin sites, activity levels, and hypertensive and hypotensive cohorts, rather than further optimization of pressure sensitivity alone [109]. Neurological disease monitoring Parkinson's disease monitoring and management Parkinson's disease (PD) monitoring illustrates the need to separate biomechanical symptom sensing from biochemical therapeutic-drug monitoring. Hydrogel-integrated triboelectric nanogenerator (TENG) sensors can quantify tremor frequency and amplitude through self-powered mechanical transduction, which may support longitudinal motor-symptom profiling outside the clinic [110]. The relevant validation step is comparison with clinical motor scales, medication state, and real-world wearing artifacts, rather than simply demonstrating tremor-responsive voltage output. This tremor-sensing platform is best classified as an on-body pilot demonstration, because it demonstrates wearable detection of tremor-related mechanical signals but has not yet been benchmarked against clinical motor scales, medication states, or longitudinal patient outcomes required for human validation. L-Dopa monitoring addresses a distinct problem. A sweat-based L-Dopa biosensor uses a functionalized electrochemical electrode and sweat-sampling interface to track a biochemical therapeutic-drug signal after medication intake (Fig. 6) [97]. This readout has a different sampling frequency, lag, and clinical decision window from tremor sensing. Future studies involving simultaneous monitoring of drug-level trends and motor fluctuations may examine whether these two signals can be temporally aligned. However, autonomous closed-loop dosing would require evidence of pharmacokinetic accuracy, patient-level variability, dosing safety, false-alarm handling, and clinician override mechanisms. This sweat L-Dopa biosensor is best classified as an analytical or device-level prototype, pending pharmacokinetic validation against plasma reference measurements in Parkinson's disease patients under clinically relevant dosing conditions. Wearable Parkinson's disease monitoring based on tremor sensing and L-Dopa tracking. (a) Stretchable, self-healable catechol-chitosan-diatom hydrogel (CCDHG) triboelectric nanogenerator integrated into a self-powered M-shaped tremor sensor. Reproduced with permission from Ref. [110]. Copyright 2021 Elsevier. (b) Representative clinical symptoms of Parkinson's disease. Reproduced with permission from Ref. [110]. Copyright 2021 Elsevier. (c) Cloud-based data fusion and machine-learning analysis of tremor signals. Reproduced with permission from Ref. [110]. Copyright 2021 Elsevier. (d) Non-invasive fingertip sweat-based monitoring of L-Dopa pharmacokinetics. Reproduced with permission from Ref. [97]. Copyright 2021 Wiley. Epilepsy-related electrophysiological monitoring and responsive interfaces Epilepsy is a chronic neurological disorder characterized by recurrent seizures, but seizure detection, seizure forecasting, EEG acquisition, and therapeutic intervention are distinct technical and clinical objectives. Wearable systems can support continuous real-world data acquisition, yet forecasting clinically actionable seizures remains an unsolved problem that requires rigorous false-alarm, latency, and reference-standard evaluation [111,112]. High-quality EEG remains central to seizure-monitoring and forecasting research. Conductive or soft interfacial materials may improve ambulatory EEG by lowering skin–electrode impedance, improving conformal contact, and reducing dehydration-related discomfort [95]. These advantages should be framed as acquisition-level improvements unless the resulting EEG data have been validated prospectively against clinical video-EEG or another accepted seizure reference. Drug-release concepts add a further translational barrier. A silk-fibroin-based hydrogel sensor combined with a microneedle array can be discussed as an early sensing–actuation concept, but it should not be presented as clinically translatable seizure therapy without evidence for false-positive handling, dose precision, response latency, long-term safety, and regulatory classification [96]. The appropriate claim is therefore an intervention concept, not clinical seizure prediction or closed-loop treatment readiness. Overall, the microneedle-integrated hydrogel platform should be viewed as a proof-of-concept closed-loop strategy rather than a clinically established seizure-intervention system, with its translational value still dependent on rigorous validation of predictive performance, therapeutic control, operational reliability, and patient safety. Gynecological health monitoring Estradiol monitoring illustrates an advanced but still investigational case of sweat-based molecular sensing for gynecological health. The clinically relevant question is not only whether estradiol can be detected at low concentration, but whether sweat estradiol can be quantitatively related to serum hormone dynamics and to defined reproductive or endocrine decision points. Accordingly, the hydrogel contribution should be specified separately from the molecular-recognition chemistry: the hydrogel-containing microfluidic/sampling interface supports sweat induction, collection, and skin contact, whereas the gold nanoparticle (AuNP)-MXene aptamer electrode provides reagentless electrochemical transduction. In the wearable estradiol platform, Fig. 7a and b anchors the system-level design and human longitudinal monitoring evidence: Fig. 7a illustrates the skin-interfaced wearable configuration, including sweat induction/collection and wireless electrochemical readout, whereas Fig. 7b summarizes on-body monitoring of estradiol fluctuations across the menstrual cycle [26]. The hydrogel-containing interface can therefore be described as a sweat-induction/collection and skin-contact component, with adhesion directly supported by the hydrogel; however, the overall platform should be classified as an advanced on-body human pilot demonstration rather than clinical validation, because the reported low-concentration detection, enzyme-linked immunosorbent assay (ELISA) agreement, and longitudinal tracking were shown only in a limited cohort without a pre-specified clinical endpoint or adequately powered validation in the intended population. Wearable, reagentless aptamer-based sensing for non-invasive estradiol monitoring in sweat. (a) Concept and system-level design of a skin-interfaced wearable sensor for female-hormone monitoring. Reproduced with permission from Ref. [26]. Copyright 2024 Springer Nature. (b) Human validation of a wearable estradiol sensor for longitudinal, non-invasive hormone monitoring. Reproduced with permission from Ref. [26]. Copyright 2024 Springer Nature. (c) Reagentless in situ detection mechanism using an AuNP-MXene electrode with a target-induced strand-displacement aptamer switch. Reproduced with permission from Ref. [26]. Copyright 2024 Springer Nature. Fig. 7c shows the molecular transduction mechanism. At the recognition interface, AuNP-MXene composite materials provide a conductive and high-surface-area electrode modification layer for aptamer immobilization, and target-induced aptamer conformational changes modulate charge-transfer behavior to generate the electrochemical signal [26]. This mechanism explains the analytical sensitivity of the device, but its translational value will depend on repeated sweat induction, ionic-strength and pH variation, skin-condition differences, menstrual-cycle time scales, and validation against serum reference measurements in larger and more diverse cohorts. Other health monitoring applications Beyond metabolic, cardiovascular, neurological, and gynecological applications, conductive hydrogels have been explored in sleep and wound-related monitoring. These areas should be treated as distinct translational scenarios because sleep analysis depends on reference-standard physiological labeling, whereas wound applications may involve compromised tissue, active therapy, infection risk, and different regulatory classifications. Sleep monitoring Sleep monitoring is a useful example in which conductive-hydrogel wearables mainly improve signal acquisition and wearing comfort, whereas clinical interpretation still depends on validation against established sleep-medicine standards. Polysomnography (PSG) remains the reference method for diagnosing obstructive sleep apnea syndrome (OSAS), while wearable platforms are better positioned at present as lower-burden screening, longitudinal trend-monitoring, or home-follow-up tools unless prospectively validated against PSG in representative cohorts. For OSAS monitoring, Fig. 8b provides the physiological rationale for using pulse-wave and optical signals: intermittent airway obstruction alters cardiopulmonary dynamics, producing changes in PPG, pulse pressure waveforms (PPW), oxygenation-related signals, and autonomic responses. This mechanism justifies multimodal wearable acquisition, but it also means that motion artifacts, sleep posture, vascular tone, skin contact pressure, and individual cardiovascular status can confound apnea-related features. The hydrogel contribution should therefore be described at the device-interface level—improving conformal contact, mechanical coupling, and long-duration signal stability—rather than as direct evidence of diagnostic performance. Fig. 8a presents the dual-modal wearable system itself: the hydrogel-enabled pulse-sensing component is combined with PPG acquisition and deep-learning analysis to classify apnea-related events with reduced power consumption [113]. This is an important device-level demonstration because the hydrogel-containing interface supports stable pulse-wave acquisition during overnight wear. However, the reported classifier remains a pilot system: the model requires external prospective validation, transparent failure reporting, and comparison with attended PSG using pre-specified metrics before it can be described as a clinically validated OSAS diagnostic device. It currently corresponds to an on-body pilot demonstration, rather than human validation against an accepted clinical reference method in the intended patient population. Dual-modal wearable pulse sensing with deep learning for sleep apnea monitoring. (a) A dual-modal wearable pulse-detection system integrated with deep learning for high-accuracy, low-power sleep apnea monitoring. Reproduced with permission from Ref. [113]. Copyright 2025 Wiley. (b) Mechanism illustration of OSAS and related cardio–respiratory alterations. The panel contrasts normal breathing versus OSAS conditions, highlighting airway patency/obstruction and corresponding changes in PPW and PPG waveforms during apnea events. Reproduced with permission from Ref. [113]. Copyright 2025 Wiley. Acute hemostasis, chronic wound monitoring, and electroactive wound therapy Hydrogel wound technologies should be separated into three clinically distinct categories: acute hemostasis, chronic wound monitoring, and electroactive wound therapy. Acute hemostatic materials are evaluated by bleeding control, gelation time, tissue adhesion, degradation, and infection risk. Chronic wound-monitoring platforms require longitudinal tracking of wound-relevant parameters and comparison with standard wound-care outcomes. Electroactive wound-therapy systems add stimulation-dose, current-distribution, heating, and failure-mode requirements. Treating these categories separately prevents hemostasis, wound monitoring, and electrostimulation from being conflated as a single translational endpoint. The wearable, battery-free, and wireless smart tree-shaped rivet-like multilayer hydrogel-based electroactive microneedle bioelectronics (GP-eMN) system should be discussed primarily as a chronic-wound monitoring and electroactive-therapy platform rather than as an acute hemorrhage device (Fig. 9a) [64,114]. In this design, the hydrogel functions as a wound-contact dressing and microneedle-integrated electrode interface, while the device architecture enables wireless sensing and electrical stimulation. Its translational gap is correspondingly device- and clinical-level: wound-healing efficacy, stimulation dosing, exudate-matrix interference, infection variability, wound-contact biocompatibility, and comparison with standard wound-care outcomes remain to be established in controlled human studies. The GP-eMN system is best classified as a preclinical device-level demonstration, because integrated sensing and electroactive therapy are shown at the platform level, but healing efficacy and safety have not yet been established in controlled human wound-care studies. By contrast, the thermosensitive PVPylated poly(D,L-alanine) (PVP-PA)/laponite hydrogel is better described as a material concept for acute hemostasis and antibacterial wound care, as shown in Fig. 9b [115]. Its relevant endpoints are gelation, tissue adhesion, bleeding time, blood loss, degradation, and local tissue response, so this PVP-PA/laponite hydrogel is best classified as an acute-hemostatic material concept rather than a validated wearable sensing or electrostimulation platform. Unless electrochemical sensing or electrostimulation is experimentally demonstrated in the same platform, those functions should not be implied. This distinction keeps acute hemostasis, chronic monitoring, and active electrotherapy aligned with their different evidence requirements. Hydrogel-enabled platforms for acute hemostasis and chronic wound management. (a) Wearable, battery-freeGP-eMN for chronic diabetic wound management. Reproduced with permission from Ref. [114]. Copyright 2025 Elsevier. (b) Injectable thermosensitive nanocomposite hydrogel (PVP-PA/laponite/water) for rapid hemostasis. Reproduced with permission from Ref. [115]. Copyright 2023 Elsevier. Biomarker detection Wearable biomarker detection should be framed as a staged analytical problem rather than as immediate clinical diagnosis. Fig. 10a is a conceptual map of the biomarker-discovery workflow: alternative biofluids such as sweat, saliva, tears, and interstitial fluid can contain electrolytes, metabolites, hormones, and proteins, and wearable platforms can integrate recognition elements with electrochemical or colorimetric readouts for longitudinal monitoring [116]. However, the inclusion of a biomarker in this workflow does not mean that the corresponding wearable assay is clinically validated. For conductive-hydrogel devices, the hydrogel contribution usually falls into one of three functions: skin-contact electrode or interface, sweat-collection or antifouling layer, or matrix for immobilizing recognition elements. Each function creates different analytical failure modes. Wearable chemical sensing for biomarker discovery. (a) Workflow of wearable-sensor-enabled biomarker discovery. Candidate biomarkers from alternative biofluids (sweat, saliva, tears, and interstitial fluid) span electrolytes, metabolites, hormones, and proteins. Molecular recognition elements (antibodies, aptamers, artificial receptors) are integrated into wearable platforms (contact lenses, mouthguards, and skin patches) with colorimetric or electrochemical readouts for continuous monitoring. Circulating C-reactive protein (CRP) is highlighted as a systemic inflammation marker accessible with sweat. Reproduced with permission from Ref. [116]. Copyright 2022 Springer Nature. (b) Skin-interfaced wearable electrochemical biosensor patch for automated, non-invasive, wireless inflammation monitoring. Reproduced with permission from Ref. [98]. Copyright 2023 Springer Nature. (c) Microfluidic immunosensing patch for in situ sweat-CRP analysis. Sequential steps include reagent reconstitution, mixing, incubation, refreshment, and electrochemical detection using square-wave voltammetry (SWV). Automated sweat sampling, controlled reagent routing, and simultaneous physicochemical parameter monitoring ensure accurate, real-time quantification. Reproduced with permission from Ref. [98]. Copyright 2023 Springer Nature. This distinction is particularly important for systemic protein biomarkers. Small metabolites such as lactate, uric acid, or glucose pose challenges related to dilution, sweat rate, and calibration, whereas proteins such as C-reactive protein (CRP) and cytokines, as well as hormone-related markers such as cortisol, are present in sweat at low and variable concentrations and can be affected by skin contamination, local inflammatory leakage, adsorption to device surfaces, and matrix-dependent antibody or aptamer performance. Therefore, Fig. 10a represents a discovery landscape, not evidence that all listed biomarkers are ready for wearable clinical monitoring. Fig. 10b and 10c provides a more specific example: a skin-interfaced wireless electrochemical patch for sweat-CRP monitoring, in which iontophoresis, microfluidic sweat handling, reagent routing, and electrochemical immunosensing are combined to automate CRP analysis [98]. In this platform, the skin-interfaced hydrogel component supports sweat induction and skin contact, while the graphene-based immunosensor provides electrochemical CRP transduction and the microfluidic module controls sweat delivery and reagent exchange. The reported serum–sweat correlation is important device-level evidence, but the platform remains investigational because diagnostic thresholds, sweat–serum kinetics, inter-individual variability, and longitudinal performance in clinically defined inflammatory conditions have not yet been established. The platform is best classified as an on-body pilot demonstration that nonetheless falls short of human validation against a pre-specified clinical reference method in the intended patient population and regulatory-cleared or clinically deployed use. Throughout 3.1, 3.5, each platform is evaluated by specifying the function performed by the hydrogel, the most advanced level of validation achieved, and the principal translational gap that remains. This structure keeps material function, device validation, and clinical relevance aligned within each application context. Conclusion and outlook Conductive hydrogels have become an important materials platform for wearable bioelectronics because they can combine soft mechanics, hydrated interfaces, and ionic/electronic charge transport. The key conclusion of this Review, however, is not that these properties automatically confer clinical readiness. Rather, conductive hydrogels create a set of material-enabled opportunities whose translational value depends on whether the hydrogel function, device performance, and clinical evidence are aligned. Across the application areas reviewed here, hydrogel-enabled platforms most often provide device-level feasibility: improved skin contact for electrophysiology, controlled sweat sampling for biofluid sensing, compliant pressure transduction for cardiovascular monitoring, adhesive or wound-contact interfaces for tissue management, and mechanically robust matrices for sensing/actuation concepts. These capabilities are promising, but they should be positioned as evidence-defined translational opportunities rather than as established clinical tools. The underlying functional modules, integration strategies, and resulting integrated systems are summarized in Fig. 11a. At the system level, integrating multimodal sensing functions, such as biochemical, mechanical, and electrophysiological monitoring, within a single, compact platform without signal cross-interference remains nontrivial. Furthermore, the rapid growth of high-dimensional physiological datasets places increasing demands on robust, interpretable, and clinically meaningful data processing frameworks. Without effective strategies for signal fusion, artifact suppression, and decision support, the translational value of wearable sensing data may be significantly constrained. In parallel with this staged translation pathway, Fig. 11b summarizes three interrelated system-level challenges for closed-loop hydrogel-enabled theranostics: environmental stability, signal fidelity, and long-term wear comfort. Environmental fluctuations, dehydration, freezing, mechanical deformation, baseline drift, and motion artifacts can jointly compromise sensing reliability, while prolonged adhesion may cause discomfort or skin irritation. Corresponding strategies include moisture-resistant and antifreezing encapsulation, self-calibration combined with multimodal data fusion, and breathable adhesive biointerfaces that maintain conformal contact without compromising skin tolerance. System-level design and translational roadmap for conductive-hydrogel wearable bioelectronics. (a) Overview of functional modules, integration strategies, and representative integrated systems. (b) Key challenges and corresponding strategies for closed-loop theranostic operation. (c) A staged roadmap for clinical translation. Responsible clinical translation requires treating regulatory and engineering constraints as upstream design inputs rather than post-development compliance checklists. Most platforms reviewed here remain at the in vitro or on-body pilot stage, and the gap between device-level feasibility and genuine clinical validation is substantial. Short-term demonstrations on small healthy-volunteer cohorts do not constitute clinical accuracy or safety validation; genuine validation requires a pre-specified accuracy criterion, an adequately powered and longitudinally designed study in the intended patient population (including individuals with disease-modified skin properties, altered sweat physiology, or medication-induced electrochemical interferences), and transparent reporting of failure rates, recalibration frequency, and missing data. Inter- and intra-subject variability in sweat secretion rate, stratum corneum impedance, and biofluid composition across age, disease status, and activity state can invalidate calibration assumptions derived from healthy volunteer data, a limitation that is particularly acute for sweat-based sensing modalities [117]. The full spectrum of translational-readiness criteria that must be addressed in this progression, spanning biocompatibility by cumulative contact category, skin irritation and sensitization, electrical safety, sterilization compatibility, packaging and shelf life, manufacturing reproducibility, analytical and device calibration, human-subject validation, wireless data security, and usability and reimbursement pathways, is summarized in Table 3, together with the hydrogel-specific design implication for each criterion. Table 3Clinical translational criteria for conductive-hydrogel wearable devices.Table 3#CriterionStandardHydrogel-specific translational considerations1BiocompatibilityISO 10993-1 (risk-based) [118], −5 cytotoxicity [119], −10 sensitization [120], −23 irritation [121]; within ISO 14971 [122] [121]For hydrogel wearables, biological safety should be judged against the intended contact site and total wearing time, not a single short application. Evidence from intact-skin use is not sufficient for devices intended for wounds or compromised skin.2Skin irritation & sensitizationISO 10993-23 [121]; clinical patch-test/wear-time evidenceThe hydrogel–skin interface can become reactive during prolonged occlusion, sweat accumulation and repeated peel-off cycles. Adhesion data are more meaningful when reported together with removal trauma, reapplication performance and realistic wear duration.3Electrical safetyIEC 60601-1 [123] (+ collateral standards) for active devices; ISO 14971 [122]Electrical risk depends on what the hydrogel device is designed to do. A passive sensing patch has a different safety profile from a hydrogel system that incorporates stimulation, iontophoresis, wireless power or drug delivery.4SterilizationISO 11135 [124] (EtO)/ISO 11137 [125] (radiation); residues per ISO 10993-7 [126]Sterilization should be considered before the hydrogel formulation is finalized. Hydrated networks may be damaged by steam, radiation can change crosslinking or impedance, and ethylene oxide residues are especially relevant for water-rich materials.5Packaging and shelf lifeISO 11607-1 [127] sterile barrier; MVTR, seal integrity; real-time and accelerated agingPackaging is part of the hydrogel device design, not just a storage accessory. Water loss, ion redistribution, network relaxation and oxidation of conductive fillers can shift the baseline before clinical use.6Manufacturing reproducibilityISO 13485 [128] GMP; pre-set acceptance ranges; batch release based on process capabilityBatch release should focus on the material variables that control hydrogel sensor output. Filler dispersion, oxidation state, swelling ratio, impedance and adhesion are likely to be more informative than dimensional or visual checks alone.7Analytical validationLOD, linear range, response time, hysteresis, drift, cross-sensitivity and durability cycles [129]For hydrogel sensors, sensitivity should be interpreted together with stability metrics. Changes in gel water content can alter impedance or dielectric response, so validation should include drift, hysteresis, cross-sensitivity and durability under the intended transduction mode.8Device calibrationPre-specified accuracy against an accepted reference method, for example ISO 15197 [130]/iCGM controls for glucoseCalibration should match the claimed biofluid, hydrogel sampling interface and target population. Data from healthy volunteers may not transfer to diseased skin, altered sweat chemistry, medication interference or another matrix such as ISF, saliva or tears.9Human-subject validationAdequately powered and representative cohort; longitudinal assessment; transparent failure reporting [131]Human testing should reflect how the hydrogel device will actually be worn. Sweat rate, stratum-corneum impedance, body site, age, sex, disease status and seasonal effects can all affect signals, making multi-day studies and failure reporting important.10Wireless data securityIEC 62304 [132] software lifecycle; EU MDR [133]/FDA cybersecurity; held-out, multi-batch validationWireless and algorithmic performance should be evaluated together with the hydrogel interface. Packet loss, timestamp drift, motion artifacts, triboelectric noise and production-lot variation can all affect ambulatory data quality and model generalizability.11Usability and reimbursementIEC 62366-1 [134] formative/summative human-factors evaluation; health-economic evidence; EU MDR [133]/payer pathwaysClinical adoption will depend on whether the hydrogel system is practical in its intended care setting. Usability, replacement frequency, caregiver training, the disposable-gel/reusable-electronics cost model and payer-relevant outcomes should be considered early.Abbreviations: EtO, ethylene oxide; EU MDR, European Union Medical Device Regulation; FDA, U.S. Food and Drug Administration; GMP, good manufacturing practice; iCGM, integrated continuous glucose monitoring system; ISF, interstitial fluid; LOD, limit of detection; MVTR, moisture vapor transmission rate. Clinical translational criteria for conductive-hydrogel wearable devices. Abbreviations: EtO, ethylene oxide; EU MDR, European Union Medical Device Regulation; FDA, U.S. Food and Drug Administration; GMP, good manufacturing practice; iCGM, integrated continuous glucose monitoring system; ISF, interstitial fluid; LOD, limit of detection; MVTR, moisture vapor transmission rate. As summarized in Fig. 11c, translating these advances requires progression through a staged, evidence-defined pathway: (i) material optimization co-realizing conductivity, modulus, adhesion, and dehydration resistance under defined conditions; (ii) device integration characterizing sensitivity, drift, motion-artifact rejection, cross-sensitivity, and cycling durability; (iii) standardized analytical validation of LOD (limit of detection), selectivity, and recovery against accepted reference assays; (iv) on-body pilot testing with transparent reporting of wear-time stability, skin-electrode impedance, and dropout; (v) adequately powered clinical comparison against a pre-specified reference in the intended patient population; (vi) regulatory and manufacturing readiness, encompassing ISO 10993 biological evaluation, IEC 60601-1 electrical safety for active platforms, formulation-specific sterilization validation, ISO 11607 packaging with hydration-retention and real-time shelf-life data, ISO 13485 batch reproducibility, IEC 62304 software lifecycle compliance and cybersecurity for wireless data pipelines, and IEC 62366-1 usability evaluation with representative end users; and (vii) post-market and health-economic evidence demonstrating measurable improvement in patient outcomes [[118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134]]. Critically, sterilization compatibility, filler-dispersion variability, dehydration, and patient-specific skin variability are interdependent failure pathways rather than isolated checkboxes, and the hydrogel formulation, device architecture, manufacturing process, and human factors protocol must be co-designed around a defined clinical decision endpoint from the earliest stage of development. Looking forward, the most valuable advances will be those that connect materials innovation to the specific validation barrier it is intended to overcome. New hydrogel chemistries should be designed not only for higher conductivity or stretchability, but also for hydration stability, low leachable burden, sterilization compatibility, reproducible fabrication, and stable interfacial impedance. System-level innovations should similarly report how multimodal sensing, wireless communication, energy autonomy, and algorithmic interpretation perform under realistic wear, independent validation, and clinically meaningful endpoints. This evidence-driven approach can move conductive-hydrogel wearable bioelectronics from compelling prototypes toward responsible clinical translation. CRediT authorship contribution statement Zhen-Ping Du: Conceptualization, Investigation, Methodology, Writing – original draft. Jun Wang: Methodology, Writing – review & editing. Ju-Wen Zhang: Investigation, Methodology. Ming-Hua Li: Conceptualization, Investigation, Methodology, Project administration, Writing – review & editing. Chao-Qun Yan: Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.